A PHASE 3, RANDOMISED, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 8 AND 12 WEEKS OF SIMEPREVIR (SMV) PLUS SOFOSBUVIR (SOF) IN TREATMENT-NAIVE AND -EXPERIENCED PATIENTS WITH CHRONIC HCV GENOTYPE 1 INFECTION WITHOUT CIRRHOSIS: OPTIMIST-1

被引：39

作者：

Kwo, P. ^{[1
]}

Gitlin, N. ^{[2
]}

Nahass, R. ^{[3
]}

Bernstein, D. ^{[4
]}

Rojter, S. ^{[5
]}

Schiff, E. ^{[6
]}

Davis, M. ^{[7
]}

Ruane, P. J. ^{[8
]}

Younes, Z. ^{[9
]}

Kalmeijer, R. ^{[10
]}

Peeters, M. ^{[11
]}

Lenz, O. ^{[11
]}

Fevery, B. ^{[11
]}

De La Rosa, G. ^{[12
]}

Scott, J. ^{[13
]}

Sinha, R. ^{[10
]}

Witek, J. ^{[10
]}

机构：

[1] Indiana Univ, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN USA

[2] Atlanta Gastroenterol Specialists, Atlanta, GA USA

[3] ID Care, Hillsborough, NJ USA

[4] Hofstra North Shore Long Isl Jewish Sch Med, Manhasset, NY USA

[5] Natl Res Inst, Los Angeles, CA USA

[6] Univ Miami, Schiff Ctr Liver Dis, Miami, FL USA

[7] Digest CARE South Florida Ctr Gastroenterol, W Palm Beach, FL USA

[8] Ruane Med & Liver Hlth Inst, Los Angeles, CA USA

[9] GASTRO ONE, Germantown, TN USA

[10] Janssen Res & Dev LLC, Titusville, NJ USA

[11] Janssen Infect Dis BVBA, Beerse, Belgium

[12] Janssen Global Serv LLC, Titusville, NJ USA

[13] Janssen Global Serv LLC, High Wycombe, Bucks, England

来源：

关键词：

D O I：

10.1016/S0168-8278(15)30168-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LP14

引用

页码：S270 / S270

页数：1